Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status

To evaluate and compare the performance of synthetic magnetic resonance imaging (SyMRI) in classifying benign and malignant breast lesions and predicting the expression status of immunohistochemistry (IHC) markers. We retrospectively analysed 121 patients with breast lesions who underwent dynamic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaojun, Fan, Zhichang, Jiang, Hongnan, Niu, Jinliang, Bian, Wenjin, Wang, Chen, Wang, Ying, Zhang, Runmei, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589282/
https://www.ncbi.nlm.nih.gov/pubmed/37864025
http://dx.doi.org/10.1038/s41598-023-45079-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589282/
https://www.ncbi.nlm.nih.gov/pubmed/37864025
http://dx.doi.org/10.1038/s41598-023-45079-2

Ejemplares similares